MXELOXIRI Combined With Molecular Targeted Drug in mCRC

ABSTRACT: The objective is to evaluate the efficacy and safety of modified XELOXIRI combined with molecular targeted drug as first-line therapy in patients with metastatic colorectal cancer (mCRC)

DISEASE(S): Unresectable Metastatic Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2321721 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR